Clinical trial
MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast…
NCT00003736 · Abramson Cancer Center at Penn Medicine, Other · Completed
Key facts
| NCT number | NCT00003736 |
|---|---|
| Title | MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer |
| Official title | Pilot Study: High Risk Breast Cancer Screening Pilot Study |
| Lead sponsor | Abramson Cancer Center at Penn Medicine, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | motexafin gadolinium, biopsy, breast imaging study, comparison of screening methods, magnetic resonance imaging, study of high risk factors |
| Enrollment | 200 |
| Start date | Jun 1, 1999 |
| Primary completion | Jun 1, 2002 |
| Completion | Jun 1, 2002 |
| First posted | Aug 20, 2003 |
| Last update posted | Sep 24, 2019 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: